122 related articles for article (PubMed ID: 38593918)
1. KAT7 enhances the proliferation and metastasis of head and neck squamous carcinoma by promoting the acetylation level of LDHA.
Lu Y; Wang Y; Zhang L; Ma Z; Yu K; Shu Y; Zou X; Yang J; Liu X; Wang C; Du Y; Li Q
Cancer Lett; 2024 May; 590():216869. PubMed ID: 38593918
[TBL] [Abstract][Full Text] [Related]
2. Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer.
Chen Y; Maniakas A; Tan L; Cui M; Le X; Niedzielski JS; Michel KA; Harlan CJ; Lu W; Henderson YC; Mohamed ASR; Lorenzi PL; Putluri N; Bankson JA; Sandulache VC; Lai SY
Br J Cancer; 2021 May; 124(10):1670-1679. PubMed ID: 33742144
[TBL] [Abstract][Full Text] [Related]
3. Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma.
Feng X; Zheng Z; Wang Y; Song G; Wang L; Zhang Z; Zhao J; Wang Q; Lun L
Exp Biol Med (Maywood); 2021 Mar; 246(5):538-546. PubMed ID: 33241710
[TBL] [Abstract][Full Text] [Related]
4. LASP1 promotes proliferation, metastasis, invasion in head and neck squamous cell carcinoma and through direct interaction with HSPA1A.
Chen Q; Wu K; Qin X; Yu Y; Wang X; Wei K
J Cell Mol Med; 2020 Jan; 24(2):1626-1639. PubMed ID: 31793711
[TBL] [Abstract][Full Text] [Related]
5. Specificity protein 1/microRNA-92b forms a feedback loop promoting the migration and invasion of head and neck squamous cell carcinoma.
Pang P; Fang H; Wu H; Wang S; Liu M; Jin S; Qi Z; Li Z; Liu F; Sun C
Bioengineered; 2021 Dec; 12(2):11397-11409. PubMed ID: 34905435
[TBL] [Abstract][Full Text] [Related]
6. Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma.
Bagué S; León X; Terra X; Lejeune M; Camacho M; Avilés-Jurado FX
Head Neck; 2022 Nov; 44(11):2505-2512. PubMed ID: 36207788
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus.
Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W
J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766
[TBL] [Abstract][Full Text] [Related]
8. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
[TBL] [Abstract][Full Text] [Related]
9. Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor.
Gorur A; Patiño M; Shi T; Corrales G; Takahashi H; Rangel R; Gleber-Netto FO; Pickering C; Myers JN; Cata JP
J Cell Physiol; 2021 Nov; 236(11):7698-7710. PubMed ID: 34038587
[TBL] [Abstract][Full Text] [Related]
10. G-Protein-Coupled Receptor Kinase-Interacting Protein 1 (GIT1) Promotes Head and Neck Squamous Cell Carcinoma Metastases via Activating the PI3K/AKT/mTOR Signal Pathway.
Xu R; Xu R; Wang Y; Wang W; Jiang L; Gong S
Comput Math Methods Med; 2022; 2022():6881932. PubMed ID: 35116073
[TBL] [Abstract][Full Text] [Related]
11. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
[TBL] [Abstract][Full Text] [Related]
12. Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-κB pathway in HNSCC.
Chang H; Xu Q; Li J; Li M; Zhang Z; Ma H; Yang X
Cell Death Dis; 2021 Jul; 12(8):725. PubMed ID: 34290225
[TBL] [Abstract][Full Text] [Related]
13. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis.
Jin L; Chun J; Pan C; Alesi GN; Li D; Magliocca KR; Kang Y; Chen ZG; Shin DM; Khuri FR; Fan J; Kang S
Oncogene; 2017 Jul; 36(27):3797-3806. PubMed ID: 28218905
[TBL] [Abstract][Full Text] [Related]
15. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.
Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W
Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090
[TBL] [Abstract][Full Text] [Related]
16. A novel IFNα-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma.
Ma H; Chang H; Yang W; Lu Y; Hu J; Jin S
Mol Cancer; 2020 Jan; 19(1):4. PubMed ID: 31907020
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of secreted phosphoprotein 1 affects malignant progression, prognosis, and resistance to cetuximab via the KRAS/MEK pathway in head and neck cancer.
Liu K; Hu H; Jiang H; Liu C; Zhang H; Gong S; Wei D; Yu Z
Mol Carcinog; 2020 Oct; 59(10):1147-1158. PubMed ID: 32805066
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma.
Diao P; Ge H; Song Y; Wu Y; Li J; Li Z; Yang J; Wang Y; Cheng J
J Cell Mol Med; 2019 Jun; 23(6):4269-4280. PubMed ID: 30950191
[TBL] [Abstract][Full Text] [Related]
19. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway.
Wang R; Liu X; Li X; Qian M; Yang X; Jiang Q; Wang Y; Liu H; Chen J; Wang X; Gong L
Mol Carcinog; 2024 Jun; 63(6):1079-1091. PubMed ID: 38426809
[TBL] [Abstract][Full Text] [Related]
20. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]